HDAC9 and glioblastoma: In contrast, the non-selective HDACi valproic acid enhanced the secretion of amphiregulin in glioblastoma cells, associated with concomitantly increased resistance to temozolomide [42], and in a non-malignant context, HDAC inhibition led to amphiregulin induction in oocytes [43].